BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22950503)

  • 1. Gastroprotective role of glucocorticoids during NSAID-induced gastropathy.
    Filaretova L
    Curr Pharm Des; 2013; 19(1):29-33. PubMed ID: 22950503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastroprotective role of glucocorticoid hormones during action of nonsteroidal anti-inflammatory drugs].
    Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2009 Mar; 95(3):250-61. PubMed ID: 19449781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroprotective action of glucocorticoid hormones during NSAID treatment.
    Filaretova LP; Podvigina TT; Bagaeva TR; Tanaka A; Takeuchi K
    Inflammopharmacology; 2005; 13(1-3):27-43. PubMed ID: 16259726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroprotective role of glucocorticoid hormones.
    Filaretova L; Podvigina T; Bagaeva T; Bobryshev P; Takeuchi K
    J Pharmacol Sci; 2007 Jul; 104(3):195-201. PubMed ID: 17598953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravation of nonsteroidal antiinflammatory drug gastropathy by glucocorticoid deficiency or blockade of glucocorticoid receptors in rats.
    Filaretova L; Bagaeva T; Makara GB
    Life Sci; 2002 Oct; 71(21):2457-68. PubMed ID: 12270751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroprotective agents for the prevention of NSAID-induced gastropathy.
    Ares JJ; Outt PE
    Curr Pharm Des; 1998 Feb; 4(1):17-36. PubMed ID: 10197031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAID-induced gastropathy in the elderly: understanding and avoidance.
    Moore JG; Bjorkman DJ
    Geriatrics; 1989 Aug; 44(8):51-7. PubMed ID: 2666269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From gastroprotective to ulcerogenic effects of glucocorticoids: role of long-term glucocorticoid action.
    Filaretova L; Podvigina T; Bagaeva T; Morozova O
    Curr Pharm Des; 2014; 20(7):1045-50. PubMed ID: 23782149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of non-steroidal anti-inflammatory drug gastropathy.
    Fiorucci S; Antonelli E; Morelli O; Morelli A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S6-13. PubMed ID: 10379463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of NSAID-induced gastrointestinal mucosal injury: a basis for preventing ulceration and symptoms from these agents.
    Rainsford KD
    Aliment Pharmacol Ther; 1988; 2 Suppl 1():43-55. PubMed ID: 2979284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histone deacetylation inhibition.
    Park JM; Han YM; Kangwan N; Lee SY; Jung MK; Kim EH; Hahm KB
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():80-92. PubMed ID: 25521739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH; Salena BJ; Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experimental animals and in humans.
    Pawlik T; Konturek PC; Konturek JW; Konturek SJ; Brzozowski T; Cześnikiewicz M; Plonka M; Bielanski W; Areny H
    Eur J Pharmacol; 2002 Aug; 449(1-2):1-15. PubMed ID: 12163100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of candidates for adjunctive 'gastroprotective' prostaglandins.
    Adelizzi RA
    J Am Osteopath Assoc; 1990 Jul; 90(7):598-601. PubMed ID: 2115860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.
    Graham DY
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):675-81. PubMed ID: 2642452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID, ulcers, and prostaglandins.
    Kimmey MB
    J Rheumatol Suppl; 1992 Nov; 36():68-73. PubMed ID: 1474538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandins and the prevention of non-steroidal antirheumatic drug-induced gastric lesions].
    Miederer SE
    Fortschr Med; 1989 Mar; 107(10):63-4, 67-8. PubMed ID: 2497057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.